The American Society of Health-System Pharmacists (ASHP) and the Institute for Safe Medication Practices (ISMP) last week issued a serious medication alert about colistimethate.
FDA has approved azilsartan medoxomil 40-mg and 80-mg tablets for the treatment of hypertension, either alone or in combination with other antihypertensive agents. FDA has also approved roflumilast as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations (not the relief of acute bronchospasm).
A meta-analysis of studies on recurrent venous thromboembolism; updated guidelines for management of atrial fibrillation; a meta-analysis of studies comparing generic and branded warfarin
Are surgeons at your hospital using recombinant factor VIIa to control bleeding? If so, they are probably not helping patients and could be harming them.
"Few patients who are prescribed varenicline to assist in smoking cessation remain on the therapy, according to retrospective data presented during the 45th midyear meeting of the American Society of Health Systems Pharmacists."
Diagnostic testing, narcotics, and questionable treatment modalities appear to be overused for chronic neck pain, while effective treatments such as therapeutic exercise appear to be underused, according to a study in the November issue of Arthritis Care & Research, HealthDay News reported.
FDA is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
Calcium supplementation is associated with an increased risk of myocardial infarction (MI), according to a meta-analysis published online July 29 in BMJ and reported by HealthDay News.
The FDA recently alerted pharmacists to medication error reports about mefloquine (Lariam) prescriptions calling for 250 mg daily rather than the recommended dose of 250 mg weekly for malaria prophylaxis.